{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:43:49Z","timestamp":1648723429102},"reference-count":39,"publisher":"Japanese Society of Toxicology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2008]]},"DOI":"10.2131\/jts.33.599","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T05:57:52Z","timestamp":1228111072000},"page":"599-608","source":"Crossref","is-referenced-by-count":5,"title":["Manifestation of psychiatric behaviors in a mouse model of griseofulvin-induced hepatic porphyria"],"prefix":"10.2131","volume":"33","author":[{"given":"Yoko","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Iwadate","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukino","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"},{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kawai","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Mitsumoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Anderson, K.E., Bloomer, J.R., Bonkovsky, H.L., Kushner, J.P., Pierach, C.A., Pimstone, N.R. and Desnick, R.J. (2005): Recommendations for the diagnosis and treatment of the acute porphyrias. Ann. Intern. Med., <b>142<\/b>, 439-450.","DOI":"10.7326\/0003-4819-142-6-200503150-00010"},{"key":"2","unstructured":"Berenson, M.M., Welch, V. and Garcia-Marin, J.J. (1991): Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy. J. Lab. Clin. Med., <b>118<\/b>, 89-98."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Billi de Catabbi, S.C., Faletti, A., Fuentes, F., San Mart&iacute;n de Viale, L.C. and Coch&oacute;n, A.C. (2005): Hepatic arachidonic acid metabolism is disrupted after hexachlorobenzene treatment. Toxicol. Appl. Pharmacol., <b>204<\/b>, 187-195.","DOI":"10.1016\/j.taap.2004.09.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bonkowsky, H.L. and Schady, W. (1982): Neurologic manifestations of acute porphyria. Semin. Liver Dis., <b>2<\/b>, 108-124.","DOI":"10.1055\/s-2008-1040701"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(92)90380-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Choi, S.W., Han, J.H., Lim, K.T., Cho, H.M., Chung, K.W., Sun, H.S., Park, D.H., Kim, B.S. and Seo, E.J. (1991): Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin. J. Korean Med. Sci., <b>6<\/b>, 146-156.","DOI":"10.3346\/jkms.1991.6.2.146"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(87)90209-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Davies, R., Schuurman, A., Barker, C.R., Clothier, B., Chernova, T., Higginson, F.M., Judah, D.J., Dinsdale, D., Edwards, R.E., Greaves, P., Gant, T.W. and Smith, A.G. (2005): Hepatic gene expression in protoporphyic FECH mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am. J. Pathol., <b>166<\/b>, 1041-1053.","DOI":"10.1016\/S0002-9440(10)62325-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"De Matteis, F. and Rimington, C. (1963): Disturbance of porphyrin metabolism caused by griseofulvin in mice. Br. J. Dermatol., <b>75<\/b>, 91-104.","DOI":"10.1111\/j.1365-2133.1963.tb13945.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Downey, D.C. (1999): Porphyria and chemicals. Med. Hypotheses, <b>53<\/b>, 166-171.","DOI":"10.1054\/mehy.1998.0737"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.1996.v24.pm0008781345"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Ged, C., Mendez, M., Robert, E., Lalanne, M., Lamrissi-Garcia, I., Costet, P., Daniel, J.Y., Dubus, P., Mazurier, F., Moreau-Gaudry, F. and de Verneuil, H. (2006): A knock-in mouse model of congenital erythropoietic porphyria. Genomics, <b>87<\/b>, 84-92.","DOI":"10.1016\/j.ygeno.2005.08.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hawkins, C.W., Bickers, D.R., Mukhtar, H. and Elmets, C.A. (1986): Cutaneous porphyrin photosensitization: Murine ear swelling as a marker of the acute response. J. Invest. Dermatol., <b>86<\/b>, 638-642.","DOI":"10.1111\/1523-1747.ep12275644"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Henderson, L.P. (2007): Steroid modulation of GABA<sub>A<\/sub> receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology, <b>52<\/b>, 1439-1453.","DOI":"10.1016\/j.neuropharm.2007.01.022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hift, R.J., Davidson, B.P., van der Hooft, C., Meissner, D.M. and Meissner, P.N. (2004): Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: Precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard. Clin. Chem., <b>50<\/b>, 915-923.","DOI":"10.1373\/clinchem.2003.025213"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Inafuku, K., Takamiyagi, A., Oshiro, M., Kinjo, T., Nakashima, Y. and Nonaka, S. (1999): Alteration of mRNA levels of d-aminolevulinic acid synthase, ferrochelatase and heme oxygenase-1 in griseofulvin induced protoporphyria mice. J. Dermatol. Sci., <b>19<\/b>, 189-198.","DOI":"10.1016\/S0923-1811(98)00073-5"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1002\/da.20262"},{"key":"18","unstructured":"Kamei, Y. (1989a): Recommendation method for measurement of enzyme activity in human serum. Aspartate aminotransferase. Jpn. J. Clin. Chem., <b>18<\/b>, 226-230."},{"key":"19","unstructured":"Kamei, Y. (1989b): Recommendation method for measurement of enzyme activity in human serum. Alanine aminotransferase. Jpn. J. Clin. Chem., <b>18<\/b>, 250-254."},{"key":"20","unstructured":"Kamei, Y. (1990): Recommendation method for measurement of enzyme activity in human serum. Alkaline phosphatase. Jpn. J. Clin. Chem., <b>19<\/b>, 209-212."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kochar, D.K., Pal, M., Kochar, S.K., Vyas, A., Kochar, A., Bindal, D. and Agrawal, R.P. (2007): Acute intermittent porphyria presenting with neurological emergency: Review of six cases. Neurology India, <b>55<\/b>, 413-415.","DOI":"10.4103\/0028-3886.33303"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Krijt, J., P&#353;en&aacute;k, O., Vokurka, M., Chlumsk&aacute;, A. and Fakan, F. (2003): Experimental hepatic uroporphyria induced by the diphenyl-ether herbicide fomesafen in male DBA\/2 mice. Toxicol. Appl. Pharmacol., <b>189<\/b>, 28-38","DOI":"10.1016\/S0041-008X(03)00087-5"},{"issue":"3","key":"23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/bj2430863","volume":"243","year":"1987","ISSN":"http:\/\/id.crossref.org\/issn\/0264-6021","issn-type":"print"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1038\/ng0296-195"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1126\/science.6648517"},{"key":"26","unstructured":"May, B.K., Ramana Bhasker, C., Bawden, M.J. and Cox, T.C. (1990): Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis. Mol. Biol. Med., <b>7<\/b>, 405-421."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Millward, L.M., Kelly, P., King, A. and Peters, T.J. (2005): Anxiety and depression in the acute porphyrias. J. Inherit. Metab. Dis., <b>28<\/b>, 1099-1107.","DOI":"10.1007\/s10545-005-4561-1"},{"key":"28","unstructured":"Omura, T. and Sato, R. (1964): The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., <b>239<\/b>, 2370-2378."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Ostapowicz, G., Fontana, R.J., Schi&oslash;dt, F.V., Larson, A., Davern, T.J., Han, S.H., McCashland, T.M., Shakil, A.O., Hay, J.E., Hynan, L., Crippin, J.S., Blei, A.T., Samuel, G., Reisch, J. and Lee, W.M. (2002): Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med., <b>137<\/b>, 947-954.","DOI":"10.7326\/0003-4819-137-12-200212170-00007"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Papadopoulos, V., Baraldi, M., Guilarte, T.R., Knudsen, T.B., Lacap&egrave;re, J.-J., Lindemann, P., Norenberg, M.D., Nutt, D,. Weizman, A., Zhang, M.-R. and Gavish, M. (2006): Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci., <b>27<\/b>, 402-409.","DOI":"10.1016\/j.tips.2006.06.005"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.011481398"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(78)90118-8"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.1755"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Ruscito, B.J. and Harrison, N.L. (2003): Hemoglobin metabolites mimic benzodiazepines and are possible mediators of hepatic encephalopathy. Blood, <b>102<\/b>, 1525-1528.","DOI":"10.1182\/blood-2003-03-0739"},{"key":"35","unstructured":"Sekiguchi, M. (1995): Recommendation method for measurement of enzyme activity in human serum. &gamma;-Glutamyltranspeptidase. Jpn. J. Clin. Chem., <b>24<\/b>, 106-121."},{"key":"36","unstructured":"Seth, A.K., Badminton, M.N., Mirza, D., Russell, S. and Elias, E. (2007): Liver transplantation for porphyria: Who, when, and how? Liver Transpl., <b>13<\/b>, 1219-1227."},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1038\/nn1868"},{"key":"38","unstructured":"Thunell, S. (2006): Genomic approach to acute porphyria. Physiol. Res., <b>55<\/b>, S43-S66."},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.8.2256"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/33\/5\/33_5_599\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:25:14Z","timestamp":1620962714000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/33\/5\/33_5_599\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.33.599","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}